AFP Testing Market is expected to grow at a CAGR of 7.2% during the forecast period. Global AFP Testing Market is expected to reach US$ 1.19 Bn. by 2029.AFP Testing Market Introduction and Overview
Alpha-fetoprotein (AFP) is a glycoprotein synthesized in the fetal yolk sac and liver during the gestational period. Since the discovery of this tumor-associated fetal protein in the mid-1960s, AFP has been widely used in clinical practices. An abnormal increase in the plasma AFP level in adults is considered to be a hallmark of pathological conditions, including HCC, yolk sac tumors, and gastric carcinoma.To know about the Research Methodology:- Request Free Sample Report AFP Tests are commercially available worldwide and are used for testing various cancer-related tests. Cancer is recognized as the second most reason for deaths globally. Increasing cancer cases is a key driver of the market. According to WHO, about 18 million people are suffering from cancer. Technological advancements in the testing field, rising disposable income and rapidly developing R&D activities are also augmenting the market growth. Product launches, Merger acquisitions, and joint-ventures are some of the key strategies taken up by key players of the AFP testing market. These initiatives are expected to fuel-up the demand for the AFP Testing market in the forecast period. New upcoming tests in the market for disease diagnosis are increasing the market. However, false positive or false negative results in testing are challenging the market growth. Also, lack of skilled physicians and lack of diagnosis awareness are hampering the market. The report contains a detailed analysis of Strengths, Weakness, and opportunities of the key players operating in the AFP Testing market. It also provides information on current market trends, competitive ranking analysis, regional bifurcation, turnover forecasts, industry drivers, and the key challenges. The report has profiled fourteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analysing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on availability of advanced technology and new techniques.
AFP Testing market Segment Analysis
By disease type, the liver cancer segment is expected to dominate the AFP Testing market. The liver segment is expected to be the fastest-growing segment exhibiting a CAGR of xx% in the forecast period. According to WHO, liver cancer is the leading cause for cancer deaths every year globally. The Liver Function tests (LFTs) take a look at the part of your liver that is not affected by cancer to see how well is the lover working. The tests look for levels of certain substances in the blood, such as bilirubin, ALP, AST, and GGT. The rise in levels of these substances above a certain threshold is considered as a cancer case and needs to be treated. By End-user type, hospitals held the largest share of xx% of the AFP testing market in 2022, owing to the advanced technologies available for treatment, proper care taken by the physicians and availability of favorable reimbursement policies. Government initiatives for hospital treatments are also driving the market growth.Regional Insights
North America dominated the Market share accounting for 45% of the market in 2022. This is mainly owing to the increasing incidence of chronic disease and increasing investment in cancer research. According to National Cancer Institute, about 1 million cases of cancer are diagnosed in the U.S. which are contributing to the growth of this segment. However, the Asia Pacific region is projected to be the fastest-growing during the forecast period 2023-2029. This is owing to increasing disposable income and increasing healthcare expenditure. Asian countries are in the process of developing their healthcare infrastructure. The governments of Asian countries are developing favorable and affordable policies for treatments, thereby fuelling the market growth.Scope of the AFP Testing Market Report: Inquire before buying
AFP Testing Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 0.73 Bn. Forecast Period 2023 to 2029 CAGR: 7.2% Market Size in 2029: US $ 1.19 Bn. Segments Covered: by Disease Liver Cancer Testes Cancer Biliary Tract Cancer Stomach Cancer Pancreatic Cancer by Application Hospitals Clinics Others AFP Testing Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina and Rest of South America)Key Players operating the AFP Testing Market are:
1. Biomedical Diagnostics 2. Abbott Laboratories 3. Bio-Rad Laboratories 4. Kreatech Diagnostics 5. Beckman Coulter 6. Roche Diagnostics 7. Thermo Fisher Scientific 8. Dickinson and Company 9. Geno Technology 10.GeneCopoeia, Inc 11.Sartorius 12.Mackay Life Sciences 13.Panacea Pharmaceuticals 14.Siemens Healthcare Frequently Asked Questions: 1. Which region has the largest share in Global AFP Testing Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global AFP Testing Market? Ans: The Global AFP Testing Market is growing at a CAGR of 7.2% during forecasting period 2023-2029. 3. What is scope of the Global AFP Testing Market report? Ans: Global market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. What was the Global AFP Testing market size in 2022? Ans: The Global AFP Testing market was valued at US$ 0.73 Bn in 2022. 5. What is the study period of this Market? Ans: The Global market is studied from 2022 to 2029.
Global AFP Testing Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: AFP TESTING Market Size, By Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global AFP TESTING Market Analysis and Forecast 6.1. AFP TESTING Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global AFP TESTING Market Analysis and Forecast, By Disease type 7.1. Introduction and Definition 7.2. Key Findings 7.3. AFP TESTING Market Value Share Analysis, By Disease type 7.4. AFP TESTING Market Size (US$ Mn) Forecast, By Disease type 7.5. AFP TESTING Market Analysis, By Disease type 7.6. AFP TESTING Market Attractiveness Analysis, By Disease type 8. Global AFP TESTING Market Analysis and Forecast, By Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. AFP TESTING Market Value Share Analysis, By Application 8.4. AFP TESTING Market Size (US$ Mn) Forecast, By Application 8.5. AFP TESTING Market Analysis, By Application 8.6. AFP TESTING Market Attractiveness Analysis, By Application 9. Global AFP TESTING Market Analysis, By Region 9.1. AFP TESTING Market Value Share Analysis, By Region 9.2. AFP TESTING Market Size (US$ Mn) Forecast, By Region 9.3. AFP TESTING Market Attractiveness Analysis, By Region 10. North America AFP TESTING Market Analysis 10.1. Key Findings 10.2. North America AFP TESTING Market Overview 10.3. North America AFP TESTING Market Value Share Analysis, By Disease type 10.4. North America AFP TESTING Market Forecast, By Disease type 10.4.1. Liver Cancer 10.4.2. Testes Cancer 10.4.3. Biliary Tract Cancer 10.4.4. Stomach Cancer 10.4.5. Pancreatic Cancer 10.5. North America AFP TESTING Market Value Share Analysis, By Application 10.6. North America AFP TESTING Market Forecast, By Application 10.6.1. Hospitals 10.6.2. Clinics 10.6.3. Others 10.7. North America AFP TESTING Market Value Share Analysis, By Country 10.8. North America AFP TESTING Market Forecast, By Country 10.8.1. U.S. 10.8.2. Canada 10.8.3. Mexico 10.9. North America AFP TESTING Market Analysis, By Country 10.10. U.S. AFP TESTING Market Forecast, By Disease type 10.10.1. Liver Cancer 10.10.2. Testes Cancer 10.10.3. Biliary Tract Cancer 10.10.4. Stomach Cancer 10.10.5. Pancreatic Cancer 10.11. U.S. AFP TESTING Market Forecast, By Application 10.11.1. Hospitals 10.11.2. Clinics 10.11.3. Others 10.12. Canada AFP TESTING Market Forecast, By Disease type 10.12.1. Liver Cancer 10.12.2. Testes Cancer 10.12.3. Biliary Tract Cancer 10.12.4. Stomach Cancer 10.12.5. Pancreatic Cancer 10.13. Canada AFP TESTING Market Forecast, By Application 10.13.1. Hospitals 10.13.2. Clinics 10.13.3. Others 10.14. Mexico AFP TESTING Market Forecast, By Disease type 10.14.1. Liver Cancer 10.14.2. Testes Cancer 10.14.3. Biliary Tract Cancer 10.14.4. Stomach Cancer 10.14.5. Pancreatic Cancer 10.15. Mexico AFP TESTING Market Forecast, By Application 10.15.1. Hospitals 10.15.2. Clinics 10.15.3. Others 10.16. North America AFP TESTING Market Attractiveness Analysis 10.16.1. By Disease type 10.16.2. By Application 10.17. PEST Analysis 10.18. Key Trends 10.19. Key Developments 11. Europe AFP TESTING Market Analysis 11.1. Key Findings 11.2. Europe AFP TESTING Market Overview 11.3. Europe AFP TESTING Market Value Share Analysis, By Disease type 11.4. Europe AFP TESTING Market Forecast, By Disease type 11.4.1. Liver Cancer 11.4.2. Testes Cancer 11.4.3. Biliary Tract Cancer 11.4.4. Stomach Cancer 11.4.5. Pancreatic Cancer 11.5. Europe AFP TESTING Market Value Share Analysis, By Application 11.6. Europe AFP TESTING Market Forecast, By Application 11.6.1. Hospitals 11.6.2. Clinics 11.6.3. Others 11.7. Europe AFP TESTING Market Value Share Analysis, By Country 11.8. Europe AFP TESTING Market Forecast, By Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Sweden 11.8.7. CIS countries 11.8.8. Rest of Europe 11.9. Germany AFP TESTING Market Forecast, By Disease type 11.9.1. Liver Cancer 11.9.2. Testes Cancer 11.9.3. Biliary Tract Cancer 11.9.4. Stomach Cancer 11.9.5. Pancreatic Cancer 11.10. Germany AFP TESTING Market Forecast, By Application 11.10.1. Hospitals 11.10.2. Clinics 11.10.3. Others 11.11. U.K. AFP TESTING Market Forecast, By Disease type 11.11.1. Liver Cancer 11.11.2. Testes Cancer 11.11.3. Biliary Tract Cancer 11.11.4. Stomach Cancer 11.11.5. Pancreatic Cancer 11.12. U.K. AFP TESTING Market Forecast, By Application 11.12.1. Hospitals 11.12.2. Clinics 11.12.3. Others 11.13. France AFP TESTING Market Forecast, By Disease type 11.13.1. Liver Cancer 11.13.2. Testes Cancer 11.13.3. Biliary Tract Cancer 11.13.4. Stomach Cancer 11.13.5. Pancreatic Cancer 11.14. France AFP TESTING Market Forecast, By Application 11.14.1. Hospitals 11.14.2. Clinics 11.14.3. Others 11.15. Italy AFP TESTING Market Forecast, By Disease type 11.15.1. Liver Cancer 11.15.2. Testes Cancer 11.15.3. Biliary Tract Cancer 11.15.4. Stomach Cancer 11.15.5. Pancreatic Cancer 11.16. Italy AFP TESTING Market Forecast, By Application 11.16.1. Hospitals 11.16.2. Clinics 11.16.3. Others 11.17. Spain AFP TESTING Market Forecast, By Disease type 11.17.1. Liver Cancer 11.17.2. Testes Cancer 11.17.3. Biliary Tract Cancer 11.17.4. Stomach Cancer 11.17.5. Pancreatic Cancer 11.18. Spain AFP TESTING Market Forecast, By Application 11.18.1. Hospitals 11.18.2. Clinics 11.18.3. Others 11.19. Sweden AFP TESTING Market Forecast, By Disease type 11.19.1. Liver Cancer 11.19.2. Testes Cancer 11.19.3. Biliary Tract Cancer 11.19.4. Stomach Cancer 11.19.5. Pancreatic Cancer 11.20. Sweden AFP TESTING Market Forecast, By Application 11.20.1. Hospitals 11.20.2. Clinics 11.20.3. Others 11.21. CIS countries AFP TESTING Market Forecast, By Disease type 11.21.1. Liver Cancer 11.21.2. Testes Cancer 11.21.3. Biliary Tract Cancer 11.21.4. Stomach Cancer 11.21.5. Pancreatic Cancer 11.22. CIS countries AFP TESTING Market Forecast, By Application 11.22.1. Hospitals 11.22.2. Clinics 11.22.3. Others 11.23. Rest of Europe AFP TESTING Market Forecast, By Disease type 11.23.1. Liver Cancer 11.23.2. Testes Cancer 11.23.3. Biliary Tract Cancer 11.23.4. Stomach Cancer 11.23.5. Pancreatic Cancer 11.24. Rest of Europe AFP TESTING Market Forecast, By Application 11.24.1. Hospitals 11.24.2. Clinics 11.24.3. Others 11.25. Europe AFP TESTING Market Attractiveness Analysis 11.25.1. By Application 11.25.2. By Disease type 11.26. PEST Analysis 11.27. Key Trends 11.28. Key Developments 12. Asia Pacific AFP TESTING Market Analysis 12.1. Key Findings 12.2. Asia Pacific AFP TESTING Market Overview 12.3. Asia Pacific AFP TESTING Market Value Share Analysis, By Disease type 12.4. Asia Pacific AFP TESTING Market Forecast, By Disease type 12.4.1. Liver Cancer 12.4.2. Testes Cancer 12.4.3. Biliary Tract Cancer 12.4.4. Stomach Cancer 12.4.5. Pancreatic Cancer 12.5. Asia Pacific AFP TESTING Market Value Share Analysis, By Application 12.6. Asia Pacific AFP TESTING Market Forecast, By Application 12.6.1. Hospitals 12.6.2. Clinics 12.6.3. Others 12.7. Asia Pacific AFP TESTING Market Value Share Analysis, By Country 12.8. Asia Pacific AFP TESTING Market Forecast, By Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. South Korea 12.8.5. Australia 12.8.6. ASEAN 12.8.7. Rest of Asia Pacific 12.9. Asia Pacific AFP TESTING Market Analysis, By Country 12.10. China AFP TESTING Market Forecast, By Disease type 12.10.1. Liver Cancer 12.10.2. Testes Cancer 12.10.3. Biliary Tract Cancer 12.10.4. Stomach Cancer 12.10.5. Pancreatic Cancer 12.11. China AFP TESTING Market Forecast, By Application 12.11.1. Hospitals 12.11.2. Clinics 12.11.3. Others 12.12. India AFP TESTING Market Forecast, By Disease type 12.12.1. Liver Cancer 12.12.2. Testes Cancer 12.12.3. Biliary Tract Cancer 12.12.4. Stomach Cancer 12.12.5. Pancreatic Cancer 12.13. India AFP TESTING Market Forecast, By Application 12.13.1. Hospitals 12.13.2. Clinics 12.13.3. Others 12.14. Japan AFP TESTING Market Forecast, By Disease type 12.14.1. Liver Cancer 12.14.2. Testes Cancer 12.14.3. Biliary Tract Cancer 12.14.4. Stomach Cancer 12.14.5. Pancreatic Cancer 12.15. Japan AFP TESTING Market Forecast, By Application 12.15.1. Hospitals 12.15.2. Clinics 12.15.3. Others 12.16. South Korea AFP TESTING Market Forecast, By Disease type 12.16.1. Liver Cancer 12.16.2. Testes Cancer 12.16.3. Biliary Tract Cancer 12.16.4. Stomach Cancer 12.16.5. Pancreatic Cancer 12.17. South Korea AFP TESTING Market Forecast, By Application 12.17.1. Hospitals 12.17.2. Clinics 12.17.3. Others 12.18. Australia AFP TESTING Market Forecast, By Disease type 12.18.1. Liver Cancer 12.18.2. Testes Cancer 12.18.3. Biliary Tract Cancer 12.18.4. Stomach Cancer 12.18.5. Pancreatic Cancer 12.19. Australia AFP TESTING Market Forecast, By Application 12.19.1. Hospitals 12.19.2. Clinics 12.19.3. Others 12.20. ASEAN AFP TESTING Market Forecast, By Disease type 12.20.1. Liver Cancer 12.20.2. Testes Cancer 12.20.3. Biliary Tract Cancer 12.20.4. Stomach Cancer 12.20.5. Pancreatic Cancer 12.21. ASEAN AFP TESTING Market Forecast, By Application 12.21.1. Hospitals 12.21.2. Clinics 12.21.3. Others 12.22. Rest of Asia Pacific AFP TESTING Market Forecast, By Disease type 12.22.1. Liver Cancer 12.22.2. Testes Cancer 12.22.3. Biliary Tract Cancer 12.22.4. Stomach Cancer 12.22.5. Pancreatic Cancer 12.23. Rest of Asia Pacific AFP TESTING Market Forecast, By Application 12.23.1. Hospitals 12.23.2. Clinics 12.23.3. Others 12.24. Asia Pacific AFP TESTING Market Attractiveness Analysis 12.24.1. By Disease type 12.24.2. By Application 12.25. PEST Analysis 12.26. Key Trends 12.27. Key Developments 13. Middle East & Africa AFP TESTING Market Analysis 13.1. Key Findings 13.2. Middle East & Africa AFP TESTING Market Overview 13.3. Middle East & Africa AFP TESTING Market Value Share Analysis, By Disease type 13.4. Middle East & Africa AFP TESTING Market Forecast, By Disease type 13.4.1. Liver Cancer 13.4.2. Testes Cancer 13.4.3. Biliary Tract Cancer 13.4.4. Stomach Cancer 13.4.5. Pancreatic Cancer 13.5. Middle East & Africa AFP TESTING Market Value Share Analysis, By Application 13.6. Middle East & Africa AFP TESTING Market Forecast, By Application 13.6.1. Hospitals 13.6.2. Clinics 13.6.3. Others 13.7. Middle East & Africa AFP TESTING Market Value Share Analysis, By Country 13.8. Middle East & Africa AFP TESTING Market Forecast, By Country 13.8.1. GCC Countries 13.8.2. South Africa 13.8.3. Nigeria 13.8.4. Egypt 13.8.5. Rest of Middle East & Africa 13.9. Middle East & Africa AFP TESTING Market Analysis, By Country 13.10. GCC Countries AFP TESTING Market Forecast, By Disease type 13.10.1. Liver Cancer 13.10.2. Testes Cancer 13.10.3. Biliary Tract Cancer 13.10.4. Stomach Cancer 13.10.5. Pancreatic Cancer 13.11. GCC Countries AFP TESTING Market Forecast, By Application 13.11.1. Hospitals 13.11.2. Clinics 13.11.3. Others 13.12. South Africa AFP TESTING Market Forecast, By Disease type 13.12.1. Liver Cancer 13.12.2. Testes Cancer 13.12.3. Biliary Tract Cancer 13.12.4. Stomach Cancer 13.12.5. Pancreatic Cancer 13.13. South Africa AFP TESTING Market Forecast, By Application 13.13.1. Hospitals 13.13.2. Clinics 13.13.3. Others 13.14. Nigeria AFP TESTING Market Forecast, By Disease type 13.14.1. Liver Cancer 13.14.2. Testes Cancer 13.14.3. Biliary Tract Cancer 13.14.4. Stomach Cancer 13.14.5. Pancreatic Cancer 13.15. Nigeria AFP TESTING Market Forecast, By Application 13.15.1. Hospitals 13.15.2. Clinics 13.15.3. Others 13.16. Egypt AFP TESTING Market Forecast, By Disease type 13.16.1. Liver Cancer 13.16.2. Testes Cancer 13.16.3. Biliary Tract Cancer 13.16.4. Stomach Cancer 13.16.5. Pancreatic Cancer 13.17. Egypt AFP TESTING Market Forecast, By Application 13.17.1. Hospitals 13.17.2. Clinics 13.17.3. Others 13.18. Rest of Middle East & Africa AFP TESTING Market Forecast, By Disease type 13.18.1. Liver Cancer 13.18.2. Testes Cancer 13.18.3. Biliary Tract Cancer 13.18.4. Stomach Cancer 13.18.5. Pancreatic Cancer 13.19. Rest of Middle East & Africa AFP TESTING Market Forecast, By Application 13.19.1. Hospitals 13.19.2. Clinics 13.19.3. Others 13.20. Middle East & Africa AFP TESTING Market Attractiveness Analysis 13.20.1. By Disease type 13.20.2. By Application 13.21. PEST Analysis 13.22. Key Trends 13.23. Key Developments 14. South America AFP TESTING Market Analysis 14.1. Key Findings 14.2. South America AFP TESTING Market Overview 14.3. South America AFP TESTING Market Value Share Analysis, By Disease type 14.4. South America AFP TESTING Market Forecast, By Disease type 14.4.1. Liver Cancer 14.4.2. Testes Cancer 14.4.3. Biliary Tract Cancer 14.4.4. Stomach Cancer 14.4.5. Pancreatic Cancer 14.5. South America AFP TESTING Market Value Share Analysis, By Application 14.6. South America AFP TESTING Market Forecast, By Application 14.6.1. Hospitals 14.6.2. Clinics 14.6.3. Others 14.7. South America AFP TESTING Market Value Share Analysis, By Country 14.8. South America AFP TESTING Market Forecast, By Country 14.8.1. Brazil 14.8.2. Colombia 14.8.3. Argentina 14.8.4. Rest of South America 14.9. South America AFP TESTING Market Analysis, By Country 14.10. Brazil AFP TESTING Market Forecast, By Disease type 14.10.1. Liver Cancer 14.10.2. Testes Cancer 14.10.3. Biliary Tract Cancer 14.10.4. Stomach Cancer 14.10.5. Pancreatic Cancer 14.11. Brazil AFP TESTING Market Forecast, By Application 14.11.1. Hospitals 14.11.2. Clinics 14.11.3. Others 14.12. Colombia AFP TESTING Market Forecast, By Disease type 14.12.1. Liver Cancer 14.12.2. Testes Cancer 14.12.3. Biliary Tract Cancer 14.12.4. Stomach Cancer 14.12.5. Pancreatic Cancer 14.13. Colombia AFP TESTING Market Forecast, By Application 14.13.1. Hospitals 14.13.2. Clinics 14.13.3. Others 14.14. Argentina AFP TESTING Market Forecast, By Disease type 14.14.1. Liver Cancer 14.14.2. Testes Cancer 14.14.3. Biliary Tract Cancer 14.14.4. Stomach Cancer 14.14.5. Pancreatic Cancer 14.15. Argentina AFP TESTING Market Forecast, By Application 14.15.1. Hospitals 14.15.2. Clinics 14.15.3. Others 14.16. Rest of South America AFP TESTING Market Forecast, By Disease type 14.16.1. Liver Cancer 14.16.2. Testes Cancer 14.16.3. Biliary Tract Cancer 14.16.4. Stomach Cancer 14.16.5. Pancreatic Cancer 14.17. Rest of South America AFP TESTING Market Forecast, By Application 14.17.1. Hospitals 14.17.2. Clinics 14.17.3. Others 14.18. South America AFP TESTING Market Attractiveness Analysis 14.18.1. By Disease type 14.18.2. By Application 14.19. PEST Analysis 14.20. Key Trends 14.21. Key Developments 15. Company Profiles 15.1. Market Share Analysis, By Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players By price, presence, market share, Application, and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A By Regions, Investment and Application 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Biomedical Diagnostics 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Development Footprint 15.3.2. Abbott Laboratories 15.3.3. Bio-Rad Laboratories 15.3.4. Kreatech Diagnostics 15.3.5. Beckman Coulter 15.3.6. Roche Diagnostics 15.3.7. Thermo Fisher Scientific 15.3.8. Dickinson and Company 15.3.9. Geno Technology 15.3.10. GeneCopoeia, Inc 15.3.11. Sartorius 15.3.12. Mackay Life Sciences 15.3.13. Panacea Pharmaceuticals 15.3.14. Siemens Healthcare